Dynamics of iron status in chronic hemodialysis patients -measurement of iron loss and periodic supplementation-

Dynamics of iron status in chronic hemodialysis patients -measurement of iron loss and periodic supplementation- - Dynamics of iron status in chronic hemodialysis patients

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000019305

Enrollment

250

Registered

2015-10-09

Start date

2015-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic hemodialysis patients

Interventions

periodic iron supplementation for one year

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: chronic hemodialysis patients

Exclusion criteria

Exclusion criteria: 1) active malignancy, hematological disorder, iron looser by gastro-intestinal bleeding, etc. 2) allergy against ESA 3) pregnant or considering pregnanct woman, lactating woman 4) patients attending other clinical trials 5) improper patien

Design outcomes

Primary

Measure	Time frame
annual iron status	—

Secondary

Measure	Time frame
hemoglobin, serum iron, transferrin satulation rate, ferritin, dose of erythropoiesis stumulating agent	—

Countries

Japan

Contacts

Public ContactTatsuo Tsukamoto

Kyoto University Hospital Department of nephrology

ttsukamo@kuhp.kyoto-u.ac.jp+81-75-751-3860

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026